Pharmacologic blockade of the left stellate ganglion using a drug-reservoir-pump system.
Patients suffering from the long QT syndrome (LQTS) are threatened by sudden arrhythmic cardiac death. This case report describes a new therapeutic approach to ventricular tachyarrhythmias refractory to oral pharmacological treatment (propranolol + phenytoin) using a drug-reservoir-pump system for the pharmacologic blockage of the left stellate ganglion.
Hoepp
H W
HW
Medical Clinic III, University of Cologne, Federal Republic of Germany.
Eggeling
T
T
Hombach
V
V
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005260:Female; D005730:Ganglionic Blockers / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D015918:Infusion Pumps, Implantable; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D008619:Mepivacaine / Q000008:administration & dosage* / Q000627:therapeutic use; D013233:Stellate Ganglion / Q000187:drug effects* / Q000503:physiopathology
D005730:Ganglionic Blockers; D008619:Mepivacaine